SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-002946
Filing Date
2019-05-06
Accepted
2019-05-03 19:05:34
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050319p.htm 10-Q 389070
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8988
3 EXHIBIT 31.2 exh_312.htm EX-31.2 9074
4 EXHIBIT 32.1 exh_321.htm EX-32.1 4865
  Complete submission text file 0001171843-19-002946.txt   2957468

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE anik-20190331.xml EX-101.INS 475326
6 XBRL SCHEMA FILE anik-20190331.xsd EX-101.SCH 47054
7 XBRL CALCULATION FILE anik-20190331_cal.xml EX-101.CAL 38506
8 XBRL DEFINITION FILE anik-20190331_def.xml EX-101.DEF 285080
9 XBRL LABEL FILE anik-20190331_lab.xml EX-101.LAB 236213
10 XBRL PRESENTATION FILE anik-20190331_pre.xml EX-101.PRE 310795
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 19797709
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services